Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-05-25 Hayden Michael R Director Exercise or conversion · Stock Option (Right to Buy) −8,230 0
2016-04-28 TARNOW MICHAEL M Director Exercise or conversion +1,543 $3.35 $5K 56,710
2016-04-28 TARNOW MICHAEL M Director Gift −1,543 55,167
2016-04-28 TARNOW MICHAEL M Director Exercise or conversion · Stock Option (Right to Buy) −1,543 0
2016-04-04 WINQUIST RAYMOND Head, Translational Research Grant or award · Stock Option (Right to Buy) +35,000 35,000
2016-03-11 ROBIN SHERRINGTON SVP Bus. & Corp. Development Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-03-11 GOLDBERG Y. PAUL VP, Clinical Development Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-03-11 MORTIMER IAN CFO & COO Grant or award · Stock Option (Right to Buy) +40,000 40,000
2016-03-11 COHEN CHARLES J. VP, Biology Grant or award · Stock Option (Right to Buy) +25,000 25,000
2016-03-11 PIMSTONE SIMON N. President & CEO Grant or award · Stock Option (Right to Buy) +50,000 50,000
2016-02-08 EMPFIELD JAMES R. SVP, Drug Discovery Grant or award · Stock Option (Right to Buy) +40,000 40,000
2015-12-18 ROBIN SHERRINGTON SVP Bus. & Corp. Development Grant or award · Stock Option (Right to Buy) +15,000 15,000
2015-12-18 PIMSTONE SIMON N. President & CEO Grant or award · Stock Option (Right to Buy) +40,000 40,000
2015-12-18 MORTIMER IAN CFO & COO Grant or award · Stock Option (Right to Buy) +25,000 25,000
2015-12-18 GOLDBERG Y. PAUL VP of Clinical Development Grant or award · Stock Option (Right to Buy) +15,000 15,000
2015-12-18 COHEN CHARLES J. VP, Biology Grant or award · Stock Option (Right to Buy) +15,000 15,000
2015-12-16 ROBIN SHERRINGTON SVP Bus. & Corp. Development Exercise or conversion +411 $5.22 $2K 4,251
2015-12-16 ROBIN SHERRINGTON SVP Bus. & Corp. Development Shares withheld for taxes −229 $7.94 $2K 4,022
2015-12-16 ROBIN SHERRINGTON SVP Bus. & Corp. Development Exercise or conversion · Stock Option (Right to Buy) −411 0
2015-12-11 AZAB MOHAMMAD Director Exercise or conversion +2,469 $5.22 $13K 4,938

Page 35 of 42 · 836 trades